Throughout the decades, the Danish manufacturer of health care Coloplast has undergone major changes from the local Danish manufacturing company to a truly multinational corporation. In 2001, Coloplast has spent all its production at home in three production facilities in Denmark. Ten years later, the company moved about 90 percent of production in four different countries, with the majority in Hungary and China. However, the transformation of this magnitude rarely come without problems. Coloplast relocation of production abroad have largely been carried out through a process of trial and error, without a comprehensive corporate strategy. In this process, the company had a lot of problems. Although Coloplast was in 2011 successfully identified and changed the important issues created offshoring initiatives, executive management currently facing significant challenges in understanding that companies have learned over the last 10 years and how it could Excel based on this story. "Hide
by Marcus Moller Larsen, Torben Pedersen Source: Richard Ivey School of Business Foundation 16 pages. Publication Date: Aug 02, 2012. Prod. #: W12101-PDF-ENG
Related Case Solutions & Analyses:
Cameco in Kyrgyzstan: Corporate Social Responsibility Abroad
Execution: The Missing Link in Retail Operations
Snow Canyon Resort: Paradise Ski Lift
Three Jays Corporation
Sproxil: Saving Lives Through Technology and Social Enterprise
Emirates Aviation Industry
Cincinnati Children’s Hospital Medical Center, Video Supplement 2012
Monsanto and the Monarch Butterfly
BYD Company, Ltd., Spanish Version
Supply Loops and Their Constraints: The Industrial Ecology of Recycling and Reuse
